Not available
Quote | Atossa Therapeutics Inc. (NASDAQ:ATOS)
Last: | $1.17 |
---|---|
Change Percent: | 0.0% |
Open: | $1.14 |
Close: | $1.17 |
High: | $1.17 |
Low: | $1.13 |
Volume: | 504,029 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
News | Atossa Therapeutics Inc. (NASDAQ:ATOS)
2024-07-02 16:23:54 ET More on Atossa Therapeutics Atossa stock climbs 11% on breast cancer drug data ATOS, SMR and EIGR are among pre market gainers Seeking Alpha’s Quant Rating on Atossa Therapeutics Historical earnings data for Atossa Therapeutics ...
SEATTLE, July 02, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), today announced the appointment of Heather Rees as the Company’s new Chief Financial Officer (CFO). Ms. Rees most recently served as Atossa’s ...
Message Board Posts | Atossa Therapeutics Inc. (NASDAQ:ATOS)
Subject | By | Source | When |
---|---|---|---|
Wow. No comments? | killrEngineer | investorshub | 06/28/2023 2:55:37 PM |
MomentumIts trading | 4MVault | investorshub | 06/26/2023 2:08:03 PM |
$ATOS Lets go go go go... Up up and away we go. | DrHarleyboy | investorshub | 06/26/2023 10:09:55 AM |
$ATOS bears and bulls | DrHarleyboy | investorshub | 06/26/2023 1:31:57 AM |
$ATOS MomentumIts gaining | willlbone | investorshub | 06/25/2023 2:39:32 AM |
News, Short Squeeze, Breakout and More Instantly...
Atossa Therapeutics Inc. Company Name:
ATOS Stock Symbol:
NASDAQ Market:
Atossa Therapeutics Inc. Website:
SEATTLE, July 02, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), today announced the appointment of Heather Rees as the Company’s new Chief Financial Officer (CFO). Ms. Rees most recently served as Atossa’s ...
SEATTLE, June 28, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced protocol changes in the previously initiated study to evaluate Atossa’s proprietary (Z)-endoxifen in combination with abemaciclib (VER...
SEATTLE, June 17, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), today announced its expected upcoming inclusion in the Russell 3000 ® Index, according to preliminary Russell reconstruction information posted on ...